Cargando…
Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
Pancreatic cancer is one of the cancer types with poor prognosis and high rate of mortality. Diagnostic modalities for early detection of pancreatic cancer have been among the academic concerns. On account of the potential role of immunohistochemistry (IHC) biomarkers in overcoming certain limitatio...
Autor principal: | Luu, Tuan Trong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720928/ https://www.ncbi.nlm.nih.gov/pubmed/34988027 http://dx.doi.org/10.3389/fonc.2021.799025 |
Ejemplares similares
-
Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
por: Luu, Tuan
Publicado: (2021) -
Reduced Cancer Screening Due to Lockdowns of the COVID-19 Pandemic: Reviewing Impacts and Ways to Counteract the Impacts
por: Luu, Tuan
Publicado: (2022) -
Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer
por: Zhang, Xiaojie, et al.
Publicado: (2022) -
Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022) -
The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
por: Rozitis, Eric, et al.
Publicado: (2020)